{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:35:33Z","timestamp":1777498533370,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2314-B-303-013-MY3"],"award-info":[{"award-number":["107-2314-B-303-013-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-303 -005 -MY2"],"award-info":[{"award-number":["108-2314-B-303 -005 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neo.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T05:44:19Z","timestamp":1634881459000},"page":"1123-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation"],"prefix":"10.1016","volume":"23","author":[{"given":"Hsuan-Shun","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2350-9873","authenticated-orcid":false,"given":"Pao-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Chao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang-Yuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2021.09.006_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2010.11.039","article-title":"Ovarian Cancer Management: the role of imaging and diagnostic challenges","volume":"78","author":"Bharwani","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.neo.2021.09.006_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.neo.2021.09.006_bib0003","first-page":"284","article-title":"Ovarian cancer statistics","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neo.2021.09.006_bib0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41379-019-0370-1","article-title":"Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions","volume":"33","author":"Wu","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.neo.2021.09.006_bib0005","doi-asserted-by":"crossref","first-page":"e13029","DOI":"10.1111\/cpr.13029","article-title":"Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis","volume":"54","author":"Mei","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1016\/j.neo.2021.09.006_bib0006","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/oxfordjournals.aje.a115076","article-title":"Mohle-Boetani, Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use","volume":"128","author":"Wu","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neo.2021.09.006_bib0007","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","article-title":"C. Ovarian Cancer Cohort, The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)","volume":"80","author":"Trabert","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.09.006_bib0008","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwi162","article-title":"Short-term oral contraceptive use and the risk of epithelial ovarian cancer","volume":"162","author":"Greer","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neo.2021.09.006_bib0009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.neo.2021.09.006_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1525-1438.2007.00804.x","article-title":"Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer","volume":"17","author":"Yang","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.neo.2021.09.006_bib0011","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0090-8258(03)00088-X","article-title":"Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population","volume":"89","author":"Yen","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.neo.2021.09.006_bib0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.neo.2021.09.006_bib0013","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2021.09.006_bib0014","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ebiom.2019.01.061","article-title":"IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation","volume":"41","author":"Hsu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neo.2021.09.006_bib0015","first-page":"13","article-title":"Ovulatory follicular fluid facilitates the full transformation process for the development of high-grade serous carcinoma","author":"Hsu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2021.09.006_bib0016","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","article-title":"Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation","volume":"30","author":"Paik","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.neo.2021.09.006_bib0017","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.09.006_bib0018","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9378(11)91579-8","article-title":"Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix","volume":"167","author":"Maines-Bandiera","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.neo.2021.09.006_bib0019","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2021.09.006_bib0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/endo.142.1.7862","article-title":"Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor","volume":"142","author":"Nishi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.neo.2021.09.006_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158266","article-title":"Platelet-derived growth factor in the ovarian follicle attracts the stromal cells of the fallopian tube fimbriae","volume":"11","author":"Yeh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2021.09.006_bib0022","first-page":"22","article-title":"Trends of opportunistic salpingectomy","author":"Ding","year":"2018","journal-title":"JSLS,"},{"key":"10.1016\/j.neo.2021.09.006_bib0023","doi-asserted-by":"crossref","first-page":"22927","DOI":"10.1016\/S0021-9258(18)41615-8","article-title":"Activation of the zymogen of hepatocyte growth factor activator by thrombin","volume":"268","author":"Shimomura","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2021.09.006_bib0024","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1074\/jbc.271.7.3615","article-title":"Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator","volume":"271","author":"Miyazawa","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2021.09.006_bib0025","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1742-4658.2010.07637.x","article-title":"Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor","volume":"277","author":"Miyazawa","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.neo.2021.09.006_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113435","article-title":"Hepatocyte growth factor activator: a proteinase linking tissue injury with repair","volume":"19","author":"Fukushima","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neo.2021.09.006_bib0027","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","article-title":"CRISPR\/Cas9-Mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma","volume":"76","author":"Walton","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.09.006_bib0028","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2741\/2760","article-title":"The biological role of HGF-MET axis in tumor growth and development of metastasis","volume":"13","author":"Lesko","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.neo.2021.09.006_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/156652408785747933","article-title":"HGF\/MET signaling in ovarian cancer","volume":"8","author":"Zhou","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.neo.2021.09.006_bib0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/1933719116648212","article-title":"Regulation of HGF and c-MET interaction in normal ovary and ovarian cancer","volume":"24","author":"Kwon","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.neo.2021.09.006_bib0031","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ijgc-00009577-200507000-00007","article-title":"Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance","volume":"15","author":"Ayhan","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.neo.2021.09.006_bib0032","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.2910580507","article-title":"Overexpression of the Met\/HGF receptor in ovarian cancer","volume":"58","author":"Di Renzo","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2021.09.006_bib0033","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00918675","article-title":"Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent","volume":"2","author":"Dimartino","year":"1977","journal-title":"Inflammation"},{"key":"10.1016\/j.neo.2021.09.006_bib0034","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.09.006_bib0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem-51-6-1239","article-title":"Biochemical characterization of peritoneal fluid in women during the menstrual cycle","volume":"51","author":"Koninckx","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neo.2021.09.006_bib0036","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1200\/JCO.2011.40.3774","article-title":"Targeting the hepatocyte growth factor-cMET axis in cancer therapy","volume":"30","author":"Blumenschein","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2021.09.006_bib0037","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2010.12.355","article-title":"Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis","volume":"121","author":"Aune","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.neo.2021.09.006_bib0038","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cas.13156","article-title":"Hepatocyte growth factor\/MET in cancer progression and biomarker discovery","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.neo.2021.09.006_bib0039","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2741\/4328","article-title":"HGF and c-Met in pathogenesis of endometrial carcinoma","volume":"20","author":"Li","year":"2015","journal-title":"Front Biosci"},{"key":"10.1016\/j.neo.2021.09.006_bib0040","doi-asserted-by":"crossref","first-page":"e79137","DOI":"10.1371\/journal.pone.0079137","article-title":"C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2021.09.006_bib0041","first-page":"165","article-title":"c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival","volume":"17","author":"Lee","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.neo.2021.09.006_bib0042","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0962-8924(98)01359-2","article-title":"Developmental roles of HGF\/SF and its receptor, the c-Met tyrosine kinase","volume":"8","author":"Birchmeier","year":"1998","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.neo.2021.09.006_bib0043","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","article-title":"Hepatocyte growth factor twenty years on: Much more than a growth factor","volume":"26","author":"Nakamura","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.neo.2021.09.006_bib0044","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1530\/rep.1.00272","article-title":"Anti-inflammatory and proliferative responses in human and ovine ovarian surface epithelial cells","volume":"128","author":"Gubbay","year":"2004","journal-title":"Reproduction"},{"key":"10.1016\/j.neo.2021.09.006_bib0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/jm00085a004","article-title":"Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists","volume":"35","author":"Harper","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.neo.2021.09.006_bib0046","series-title":"Anatomy, Abdomen and Pelvis, Ovary Corpus Luteum","author":"Oliver","year":"2021"},{"key":"10.1016\/j.neo.2021.09.006_bib0047","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1742-4658.2008.06265.x","article-title":"Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases","volume":"275","author":"Mukai","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.neo.2021.09.006_bib0048","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbamcr.2014.03.020","article-title":"Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem\/progenitor cell motility","volume":"1843","author":"Fang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neo.2021.09.006_bib0049","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/BJ20041955","article-title":"Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers","volume":"390","author":"Herter","year":"2005","journal-title":"Biochem J"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:08:45Z","timestamp":1761484125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558621000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1476558621000816"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2021.09.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.16.448625","asserted-by":"object"}]},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}